NET LOSS PER SHARE	3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NOTE 6 - NET LOSS PER SHARE: Basic and diluted net loss per share is computed by dividing the net loss for the period by the weighted average number of shares of common stock outstanding during the period. The calculation of diluted net loss per share excludes potential share issuances of common stock upon the exercise of share options, warrants, and unvested restricted stocks and unvested restricted stock units as the effect is anti-dilutive. The total number of shares of common stock related to outstanding options, warrants, restricted stock, restricted stock units, Series C Preferred Stock excluded from the calculations of diluted loss per share were 2,773,675. This amount includes 342,766 of unvested restricted stock included in the number of issued and outstanding shares as of March 31, 2023. The total number of shares of common stock related to outstanding options, warrants, restricted stock, restricted stock units, Series C Preferred Stock excluded from the calculations of diluted loss per share were 2,903,634. This amount includes 547,383 of unvested restricted stock included in the number of issued and outstanding shares as of March 31, 2022.

NET LOSS PER SHARE

3 Months Ended

Mar. 31, 2023

NOTE 6 - NET LOSS PER SHARE:

Basic and diluted net loss per share is computed by dividing the net loss for the period by the weighted average number of shares of common stock outstanding during the period. The calculation of diluted net loss per share excludes potential share issuances of common stock upon the exercise of share options, warrants, and unvested restricted stocks and unvested restricted stock units as the effect is anti-dilutive.

The total number of shares of common stock related to outstanding options, warrants, restricted stock, restricted stock units, Series C Preferred Stock excluded from the calculations of diluted loss per share were 2,773,675. This amount includes 342,766 of unvested restricted stock included in the number of issued and outstanding shares as of March 31, 2023.

The total number of shares of common stock related to outstanding options, warrants, restricted stock, restricted stock units, Series C Preferred Stock excluded from the calculations of diluted loss per share were 2,903,634. This amount includes 547,383 of unvested restricted stock included in the number of issued and outstanding shares as of March 31, 2022.